DLK1 and neoplasm: Many studies demonstrate that expression of DLK1 is elevated in a wide range of tumor types, including neuroblastoma, gliomas, breast cancer, colon cancer, pancreatic cancer, small-cell lung carcinoma, leukemia and hepatocellular carcinoma [12–18].